A detailed history of Capital Investment Services Of America, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Capital Investment Services Of America, Inc. holds 2,295 shares of ABBV stock, worth $390,953. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,295
Previous 2,245 2.23%
Holding current value
$390,953
Previous $385,000 17.66%
% of portfolio
0.05%
Previous 0.04%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$163.84 - $199.33 $8,192 - $9,966
50 Added 2.23%
2,295 $453,000
Q2 2024

Jul 19, 2024

SELL
$154.79 - $180.76 $38,697 - $45,190
-250 Reduced 10.02%
2,245 $385,000
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $398,750 - $454,339
2,495 New
2,495 $454,000
Q3 2023

Oct 13, 2023

SELL
$133.59 - $154.65 $8,950 - $10,361
-67 Reduced 2.47%
2,650 $395,000
Q1 2023

Apr 06, 2023

SELL
$144.61 - $166.54 $19,666 - $22,649
-136 Reduced 4.77%
2,717 $433,000
Q2 2022

Jul 06, 2022

SELL
$137.62 - $174.96 $82,572 - $104,976
-600 Reduced 17.38%
2,853 $437,000
Q4 2021

Jan 07, 2022

SELL
$107.43 - $135.93 $5,371 - $6,796
-50 Reduced 1.43%
3,453 $468,000
Q3 2021

Oct 01, 2021

SELL
$106.4 - $120.78 $122,360 - $138,897
-1,150 Reduced 24.72%
3,503 $378,000
Q1 2021

Apr 06, 2021

BUY
$102.3 - $112.62 $59,538 - $65,544
582 Added 14.3%
4,653 $504,000
Q4 2020

Jan 06, 2021

BUY
$80.49 - $108.67 $94,012 - $126,926
1,168 Added 40.23%
4,071 $436,000
Q3 2018

Oct 05, 2018

SELL
$88.91 - $98.84 $11,825 - $13,145
-133 Reduced 4.38%
2,903 $275,000
Q1 2018

Apr 05, 2018

SELL
$92.01 - $123.21 $46,005 - $61,605
-500 Reduced 14.14%
3,036 $287,000
Q3 2017

Oct 10, 2017

BUY
$69.85 - $89.22 $246,989 - $315,481
3,536
3,536 $314,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Capital Investment Services Of America, Inc. Portfolio

Follow Capital Investment Services Of America, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Investment Services Of America, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capital Investment Services Of America, Inc. with notifications on news.